Seeking genetic susceptibility variants for colorectal cancer: The EPICOLON consortium experience

Mutagenesis

Volumn 27, Issue 2, 2012, Pages 153-159

  Castellví Bel, Sergi ^a   Ruiz Ponte, Clara ^b   Fernández Rozadilla, Ceres ^b   Abulí, Anna ^a,c   Muñoz, Jenifer ^a   Bessa, Xavier ^c   Brea Fernández, Alejandro ^b   Ferro, Marta ^b   Giráldez, María Dolores ^a   Xicola, Rosa M ^d   Llor, Xavier ^d   Jover, Rodrigo ^e   Piqué, Josep M ^a   Andreu, Montserrat ^c   Castells, Antoni ^a   Carracedo, Angel ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 3Q; CHROMOSOME 9Q; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; PENETRANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, GENETIC;

EID: 84856898554     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger047     Document Type: Article

References (50)

1. Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) Cancer statistics, 2010. CA Cancer J. Clin., 60, 277-300.
2. Castells, A., Castellv́-Bel, S. and Balaguer, F. (2009) Concepts in familial colorectal cancer: where do we stand and what is the future? Gastroenter-ology, 137, 404-409.
3. Johnson, I. T. and Lund, E. K. (2007) Review article: nutrition, obesity and colorectal cancer. Aliment. Pharmacol. Ther., 26, 161-181. (Pubitemid 46985501)
4. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85. (Pubitemid 30451850)
5. Hemminki, K. and Chen, B. (2004) Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol. Biomarkers Prev., 13, 1253-1256. (Pubitemid 38917917)
6. Jasperson, K. W., Tuohy, T. M., Neklason, D. W. and Burt, R. W. (2010) Hereditary and familial colon cancer. Gastroenterology, 138, 2044-2058.
7. Lindor, N. M., Rabe, K., Petersen, G. M. et al. (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA, 293, 1979-1985. (Pubitemid 40570891)
8. Tenesa, A. and Dunlop, M. G. (2009) New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet., 10, 353-358.
9. Houlston, R. S., Cheadle, J., Dobbins, S. E. etal. (2010) Meta-analysis ofthree genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat. Genet., 42, 973-977.
10. Wiesner, G. L., Daley, D., Lewis, S. et al. (2003) A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2. Proc. Natl Acad. Sci. U S A, 100, 12961-12965. (Pubitemid 37340008)
11. Skoglund, J., Djureinovic, T., Zhou, X. L., Vandrovcova, J., Renkonen, E., Iselius, L., Bisgaard Peltomäki, M. L. P. and Lindblom, A. (2006) Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J. Med. Genet., 43, e7.
12. Kemp, Z. E., Carvajal-Carmona, L. G., Barclay, E. et al. (2006) Evidence of linkage to chromosome 9q22.33 in colorectal cancer kindreds from the United Kingdom. Cancer Res., 66, 5003-5006. (Pubitemid 43844919)
13. Gray-Mc Guire, C., Guda, K., Adrianto, I. et al. (2010) Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Res., 70, 5409-5418.
14. Kemp, Z., Carvajal-Carmona, L., Spain, S. et al. (2006) Evidence for a colorectal cancer susceptibility locus on chromosome 3q21-q24 from a high-density SNP genome-wide linkage scan. Hum. Mol. Genet., 15, 2903-2910. (Pubitemid 44458121)
15. Papaemmanuil, E., Carvajal-Carmona, L., Sellick, G. S. et al. (2008) Deciphering the genetics of hereditary non-syndromic colorectal cancer. Eur. J. Hum. Genet., 16, 1477-1486.
16. Picelli, S., Vandrovcova, J., Jones, S., Djureinovic, T., Skoglund, J., Zhou, X. L., Velculescu, V. E., Vogelstein, B. and Lindblom, A. (2008) Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q. BMC Cancer, 8, 87.
17. Middeldorp, A., Jagmohan-Changur, S. C., van der Klift, H. M. et al. (2010) Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer. Genes Chromosomes Cancer, 49, 539-548.
18. Guda, K., Moinova, H., He, J. et al. (2009) Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. Proc. Natl Acad. Sci. U S A, 106, 12921-12925.
19. Lubbe, S. J., Pittman, A. M., Matijssen, C. et al. (2010) Evaluation of germline BMP4 mutation as a cause of colorectal cancer. Hum. Mutat., 32, E1928-E1938.
20. Venkatachalam, R., Verwiel, E. T., Kamping, E. J. etal. (2010) Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. Int. J. Cancer, 2010 Dec 2 [Epub ahead ofprint] PMID:21128281.
21. Piñol, V., Andreu, M., Castells, A., Payá, A., Bessa, X., Rodrigo, J. and Gastrointestinal Oncology Group of the Spanish Gastroenterological Association (2004) Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study. Eur. J. Gastroenterol. Hepatol., 16, 39-45. (Pubitemid 39043701)
22. Piñol, V., Andreu, M., Castells, A., Payá, A., Bessa, X., Jover, R., Gastrointestinal Oncology Group of the Spanish Gastroenterological Association et al. (2004) Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Dis. Colon. Rectum, 47, 1192-1200. (Pubitemid 38857072)
23. Llor, X., Pons, E., Xicola, R. M. et al. (2005) Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin. Cancer Res., 11, 7304-7310. (Pubitemid 41507688)
24. Ballesté, B., Bessa, X., Piñol, V. et al. (2007) Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors. Dis. Colon. Rectum, 50, 971-980. (Pubitemid 47030192)
25. Piñol, V., Castells, A., Andreu, M. et al. (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA, 293, 1986-1994 (Pubitemid 40570892)
26. Castellv́-Bel, S., Castells, A., Strunk, M. et al. (2005) Genomic rearrange-ments in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancer. Cancer Lett., 225, 93-98. (Pubitemid 40732772)
27. Giráldez, M. D., Balaguer, F., Caldés, T. et al. (2009) Association of MUTYH and MSH6 germline mutations in colorectal cancer patients. Fam. Cancer, 8, 525-531.
28. Balaguer, F., Castellv́-Bel, S., Castells, A. et al. (2007) Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin. Gastroenterol. Hepatol., 5, 379-387. (Pubitemid 46420561)
29. Castells, A., Payá, A., Alenda, C. et al. (2006) Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency. Clin. Cancer Res., 12, 1686-1692.
30. Xicola, R. M., Llor, X., Pons, E. et al. (2007) Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J. Natl Cancer Inst., 99, 244-252.
31. Bessa, X., Ballesté, B., Andreu, M. etal. (2008) A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. Clin. Gastroenterol. Hepatol., 6, 206-214.
32. Gonzalo, V., Lozano, J. J., Muñoz, J. et al. (2010) Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. PLo S One, 5, e8777
33. Rodŕguez-Moranta, F., Castells, A., Andreu, M. et al. (2006) Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations. Am. J. Gastroenterol., 101, 1104-1111. (Pubitemid 43725327)
34. Balaguer, F. Balmaña, J. Castellv́-Bel, S. et al. (2008) Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology, 134, 39-46.
35. Balmaña, J., Balaguer, F., Castellv́-Bel, S. et al. (2008) Comparison of predictive models, clinical criteria and molecular tumour screening for the identification ofpatients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J. Med. Genet., 45, 557-563.
36. Jover, R., Zapater, P., Castells, A. et al. (2006) Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut, 55, 848-855. (Pubitemid 43764557)
37. Jover, R., Zapater, P., Castells, A. et al. (2009) The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur. J. Cancer, 45, 365-373
38. Castellv́-Bel, S., Castells, A., de Cid, R. et al. (2007) Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer. Carcinogenesis, 28, 1687-1691. (Pubitemid 47289029)
39. Fernández-Rozadilla, C., Tarŕo, R., Clofent, J. et al. (2010) Colorectal cancer susceptibility quantitative trait loci in mice as a novel approach to detect low-penetrance variants in humans: a two-stage case-control study. Cancer Epidemiol. Biomarkers Prev., 19, 619-623.
40. Fernández-Rozadilla, C., de Castro, L., Clofent, J. et al. (2010) Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohort. PLo S One, 5, e12673.
41. Tomlinson, I. P., Webb, E., Carvajal-Carmona, L. et al. (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet., 40, 623-630. (Pubitemid 351601204)
42. Pittman, A. M., Webb, E., Carvajal-Carmona, L. et al. (2008) Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. Hum. Mol. Genet., 17, 3720-3727
43. Abuĺ, A., Bessa, X., González, J. R. et al. (2010) Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype. Gastroenterology, 139, 788-796.
44. Tomlinson, I. P., Dunlop, M., Campbell, H. et al. (2010) COGENT (COlorectal cancer GENe Tics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br. J. Cancer, 102, 447-454.
45. Metzker, M. L. (2010) Sequencing technologies - the next generation. Nat. Rev. Genet., 11, 31-46.
46. International Cancer Genome Consortium, Hudson, T. J., Anderson, W. et al. (2010) International network of cancer genome projects. Nature, 464, 993-998
47. 1000 Genomes Project Consortium, Durbin, R. M., Abecasis, G. R. et al. (2010) A map of human genome variation from population-scale sequencing. Nature, 467, 1061-1073.
48. Mamanova, L., Coffey, A. J., Scott, C. E., Kozarewa, I., Turner, E. H., Kumar, A., Howard, E., Shendure, J. and Turner, D. J. (2010) Target-enrichment strategies for next-generation sequencing. Nat Methods, 7, 111-118.
49. Ng, S. B., Turner, E. H., Robertson, P. D. et al. (2009) Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272-276.
50. Teer, J. K. and Mullikin, J. C. (2010) Exome sequencing: the sweet spot before whole genomes. Hum. Mol. Genet., 19, R145-R151.